Karolina Wesołowska1, Marko Elovainio2,3, Taina Hintsa2, Markus Jokela2, Laura Pulkki-Råback4, Niina Pitkänen5, Jari Lipsanen2, Janne Tukiainen6, Leo-Pekka Lyytikäinen7,8, Terho Lehtimäki7,8, Markus Juonala9,10,11, Olli Raitakari5,12, Liisa Keltikangas-Järvinen2. 1. Institute of Behavioral Sciences, University of Helsinki, P.O. Box 9, (Siltavuorenpenger 1 A), 00014, Helsinki, Finland. karolina.wesolowska@helsinki.fi. 2. Institute of Behavioral Sciences, University of Helsinki, P.O. Box 9, (Siltavuorenpenger 1 A), 00014, Helsinki, Finland. 3. National Institute for Health and Welfare, Helsinki, Finland. 4. Institute of Behavioral Sciences and Helsinki Collegium for Advanced Studies, University of Helsinki, Helsinki, Finland. 5. Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. 6. VATT Institute for Economic Research, Helsinki, Finland. 7. School of Medicine, University of Tampere, Tampere, Finland. 8. Department of Clinical Chemistry, Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland. 9. Department of Medicine, University of Turku, Turku, Finland. 10. Division of Medicine, Turku University Hospital, Turku, Finland. 11. Murdoch Children's Research Institute, Parkville, Victoria, Australia. 12. Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
Abstract
PURPOSE: Type 2 diabetes (T2D) has been associated with depressive symptoms, but the causal direction of this association and the underlying mechanisms, such as increased glucose levels, remain unclear. We used instrumental-variable regression with a genetic instrument (Mendelian randomization) to examine a causal role of increased glucose concentrations in the development of depressive symptoms. METHOD: Data were from the population-based Cardiovascular Risk in Young Finns Study (n = 1217). Depressive symptoms were assessed in 2012 using a modified Beck Depression Inventory (BDI-I). Fasting glucose was measured concurrently with depressive symptoms. A genetic risk score for fasting glucose (with 35 single nucleotide polymorphisms) was used as an instrumental variable for glucose. RESULTS: Glucose was not associated with depressive symptoms in the standard linear regression (B = -0.04, 95% CI [-0.12, 0.04], p = .34), but the instrumental-variable regression showed an inverse association between glucose and depressive symptoms (B = -0.43, 95% CI [-0.79, -0.07], p = .020). The difference between the estimates of standard linear regression and instrumental-variable regression was significant (p = .026) CONCLUSION: Our results suggest that the association between T2D and depressive symptoms is unlikely to be caused by increased glucose concentrations. It seems possible that T2D might be linked to depressive symptoms due to low glucose levels.
PURPOSE:Type 2 diabetes (T2D) has been associated with depressive symptoms, but the causal direction of this association and the underlying mechanisms, such as increased glucose levels, remain unclear. We used instrumental-variable regression with a genetic instrument (Mendelian randomization) to examine a causal role of increased glucose concentrations in the development of depressive symptoms. METHOD: Data were from the population-based Cardiovascular Risk in Young Finns Study (n = 1217). Depressive symptoms were assessed in 2012 using a modified Beck Depression Inventory (BDI-I). Fasting glucose was measured concurrently with depressive symptoms. A genetic risk score for fasting glucose (with 35 single nucleotide polymorphisms) was used as an instrumental variable for glucose. RESULTS:Glucose was not associated with depressive symptoms in the standard linear regression (B = -0.04, 95% CI [-0.12, 0.04], p = .34), but the instrumental-variable regression showed an inverse association between glucose and depressive symptoms (B = -0.43, 95% CI [-0.79, -0.07], p = .020). The difference between the estimates of standard linear regression and instrumental-variable regression was significant (p = .026) CONCLUSION: Our results suggest that the association between T2D and depressive symptoms is unlikely to be caused by increased glucose concentrations. It seems possible that T2D might be linked to depressive symptoms due to low glucose levels.
Authors: Debbie A Lawlor; Yoav Ben-Shlomo; Shah Ebrahim; George Davey Smith; Stephen A Stansfeld; John W G Yarnell; John E J Gallacher Journal: BMJ Date: 2005-01-31
Authors: Olli T Raitakari; Markus Juonala; Tapani Rönnemaa; Liisa Keltikangas-Järvinen; Leena Räsänen; Matti Pietikäinen; Nina Hutri-Kähönen; Leena Taittonen; Eero Jokinen; Jukka Marniemi; Antti Jula; Risto Telama; Mika Kähönen; Terho Lehtimäki; Hans K Akerblom; Jorma S A Viikari Journal: Int J Epidemiol Date: 2008-02-08 Impact factor: 7.196
Authors: Beatrice A Golomb; Leena Tenkanen; Tiina Alikoski; Tuomo Niskanen; Vesa Manninen; Matti Huttunen; Sarnoff A Mednick Journal: J Clin Epidemiol Date: 2002-08 Impact factor: 6.437
Authors: Mika Kivimaki; Adam G Tabak; G David Batty; Archana Singh-Manoux; Markus Jokela; Tasnime N Akbaraly; Daniel R Witte; Eric J Brunner; Michael G Marmot; Debbie A Lawlor Journal: Diabetes Care Date: 2009-07-10 Impact factor: 19.112
Authors: A Icks; J Kruse; N Dragano; M Broecker-Preuss; U Slomiany; K Mann; K H Jöckel; R Erbel; G Giani; S Moebus Journal: Diabet Med Date: 2008-11 Impact factor: 4.359
Authors: Rebecca Carnegie; Jie Zheng; Hannah M Sallis; Hannah J Jones; Kaitlin H Wade; Jonathan Evans; Stan Zammit; Marcus R Munafò; Richard M Martin Journal: Lancet Psychiatry Date: 2019-11-20 Impact factor: 27.083